For example, Pax-5 promoted an oncogenic role in specific lymphoproliferative cancers (ex: CLL and DLBCL), whereas in mammary cancers, Pax-5 elicited tumor suppressor features and promoted cellular epithelialization [53,54]. The gene discussed is PAX5; the disease is diffuse large B-cell lymphoma.